Literature DB >> 1731931

Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes.

D A Skoufias1, L Wilson.   

Abstract

The tubulin-colchicine binding reaction appears to involve a number of intermediate steps beginning with rapid formation of a transient preequilibrium complex that is followed by one or more slow steps in which conformational changes in tubulin and colchicine lead to formation of a poorly reversible final-state complex. In the present study, we investigated the relative ability of unliganded colchicine and preformed final-stage tubulin-colchicine complex to incorporate at microtubule ends and to inhibit addition of tubulin at the net assembly ends of bovine brain microtubules in vitro. Addition of 0.1 microM final-stage tubulin-colchicine complex to suspensions of microtubules at polymer-mass steady-state resulted in rapid incorporation of one to two molecules of tubulin-colchicine complex per microtubule net assembly end concomitant with approximately 50-60% inhibition of tubulin addition. Incorporation of colchicine-tubulin complex continued slowly with time, without significant additional change in the rate of tubulin addition. In contrast, addition of unliganded colchicine to microtubule suspensions resulted in incorporation of small numbers of colchicine molecules at microtubule ends and inhibition of tubulin addition only after periods of time that varied from several minutes to approximately 20 min depending upon the concentration of colchicine. Inhibition of tubulin addition beginning with unliganded colchicine increased slowly with time, concomitant with increases in the concentration of final-state tubulin-colchicine complex and the amount of colchicine bound per microtubule end. The results indicate that inhibition of tubulin incorporation at microtubule ends is caused by colchicine-liganded tubulin in the form of a final-state complex.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731931     DOI: 10.1021/bi00118a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Characterization of the colchicine binding site on avian tubulin isotype betaVI.

Authors:  Shubhada Sharma; Barbara Poliks; Colby Chiauzzi; Rudravajhala Ravindra; Adam R Blanden; Susan Bane
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

2.  Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro.

Authors:  R J Vasquez; B Howell; A M Yvon; P Wadsworth; L Cassimeris
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

3.  Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule.

Authors:  Liwen Li; Qiu Zhang; Aifeng Liu; Xiue Li; Hongyu Zhou; Yin Liu; Bing Yan
Journal:  J Am Chem Soc       Date:  2011-04-15       Impact factor: 15.419

4.  Nanoimages show disruption of tubulin polymerization by chlorpyrifos oxon: implications for neurotoxicity.

Authors:  Hasmik Grigoryan; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-22       Impact factor: 4.219

5.  Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules.

Authors:  A Vandecandelaere; S R Martin; Y Engelborghs
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity.

Authors:  Wenqian Dong; Huafeng Zhang; Xiaonan Yin; Yuying Liu; Degao Chen; Xiaoyu Liang; Xun Jin; Jiadi Lv; Jingwei Ma; Ke Tang; Zhuowei Hu; Xiaofeng Qin; Bo Huang
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

7.  Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity.

Authors:  Sangram S Kale; Ganesh S Jedhe; Sachin N Meshram; Manas K Santra; Ernest Hamel; Gangadhar J Sanjayan
Journal:  Bioorg Med Chem Lett       Date:  2015-03-14       Impact factor: 2.823

Review 8.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.

Authors:  Olga Azarenko; Tatiana Okouneva; Keith W Singletary; Mary Ann Jordan; Leslie Wilson
Journal:  Carcinogenesis       Date:  2008-10-23       Impact factor: 4.944

10.  Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules.

Authors:  Nava Dalyot-Herman; Fernando Delgado-Lopez; David A Gewirtz; John T Gupton; Edward L Schwartz
Journal:  Biochem Pharmacol       Date:  2009-07-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.